Understanding IgE Biology
了解 IgE 生物学
基本信息
- 批准号:10375189
- 负责人:
- 金额:$ 68.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-10 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AffinityAllergensAllergicAllergic DiseaseAllergic inflammationAlternative SplicingAnaphylaxisAnatomic ModelsAntibodiesAntigensApoptosisB-Cell Antigen ReceptorB-LymphocytesBasophilsBiologicalBiologyBone MarrowBone Marrow AspirationCell DegranulationCell LineageCell Surface ReceptorsCell SurvivalCell surfaceCellsComplexDataDevelopmentDistalEvolutionFoodGene Expression ProfilingGeographyHealthHeavy-Chain ImmunoglobulinsHumanHuman VolunteersHypersensitivityIgEImmunityImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunoglobulinsIndividualInflammationInflammation MediatorsInterleukin-13Interleukin-4KnowledgeLeadLiteratureLocationLongevityMediatingMembraneMemoryMemory B-LymphocyteMessenger RNAMissionMusNaturePathogenesisPatientsPatternPeripheralPlantsPlasma CellsPlasmablastPlayProcessProductionPropertyProteinsPublic HealthRNA SplicingResearchRoleSignal TransductionSiteSourceStimulusStructure of germinal center of lymph nodeSurfaceSurface ImmunoglobulinsSystemic diseaseTestingTissuesUnited States National Institutes of HealthVariantWorkantigen bindingbasecytokinedeep sequencingdensitydisabilityexperimental studygenetic manipulationinsightmast cellmouse modelpathogenreceptor densityresponsetranscriptomics
项目摘要
Project Summary
IgE-mediated allergic disease is a growing problem. The pathogenesis of allergic disease requires that
immunoglobulin (Ig) E (IgE) molecules be produced against what are otherwise usually innocuous substances.
Upon activation in the setting of cytokines such as IL-4 or IL-13, B cells can undergo IgH CSR to IgE. IgE
secreted from B lineage cells can, in the presence of cognate antigen, activate mast cells and basophils to
release potent inflammatory mediators. While IgE responses can lead to protective immunity as a part of a
specialized responses to multicellular pathogens or other noxious threats, they also underlie allergic disease.
Allergic disease can be manifest by localized inflammation, or by multiorgan involvement, including deadly
systemic anaphylactic reactions via IgE-sensitized mast cell degranulation. Thus, the production and
dissemination of IgE play a significant role in dictating the strength and extent of tissue mast cell sensitization.
It is therefore critical to understand not only how B cell IgE production and maturation is controlled, but also the
principles underlying distribution of IgE from point of origin to distal sites throughout the body. The overall
objective of this application is to understand biological aspects of IgE production and dissemination and to gain
insights into how this is influenced in allergic disease. Emerging literature and preliminary data from the
applicant suggest a general hypothesis that biological constraints cooperate to restrict IgE dissemination under
homeostatic conditions, and that accumulation of bone marrow IgE long-lived plasma cells is an aberrancy
underlying systemic manifestations of allergic disease. This hypothesis will be tested by pursuing three specific
aims, which are: 1) to determine the mechanisms of IgE expression dynamics on IgE B cells; 2) to elucidate
mechanisms underlying IgE distribution from point of origin to effector sites; and 3) to characterize IgE plasma
cells in allergic patients. Under the first aim, IgE mRNA splicing and IgE surface density will be genetically
perturbed to examine the hypothesis that splice bias-mediated dilute IgE BCR density limits independent IgE
GC B cell evolution potential. Under the second aim, models of anatomic location-specific allergic challenge
will be deployed to examine the degree to which IgE distribution is locally biased, and the role of naïve
bystander B cells in this process. Under the third aim, bone marrow aspirations from healthy and allergic
individuals will be obtained for IgH isotype-resolved deep sequencing as well as single cell transcriptomics to
elucidate the cellular sources and biological properties of IgE in patients with long-standing severe allergies.
This contribution is significant because it is expected to elucidate a more complete picture of how IgE
responses are regulated. Ultimately, such knowledge has the potential to inform the development of new
strategies that will help to reduce the growing problem of allergic disease.
项目摘要
IgE介导的过敏性疾病是一个日益严重的问题。过敏性疾病的发病机理要求
免疫球蛋白(Ig)E(IgE)分子是针对通常是无害物质的。
在激活IL-4或IL-13等细胞因子的情况下,B细胞会经历IGE CSR到IgE。 Ige
从B谱系细胞分泌的可以在存在同源抗原的情况下激活肥大细胞和嗜碱性粒细胞
释放潜在的炎症介体。虽然IgE的反应可以导致保护性免疫
对多细胞病原体或其他有害威胁的专门反应也是过敏性疾病的基础。
过敏性疾病可以通过局部感染或多机器人参与来表现,包括致命
通过对IgE敏感的肥大细胞脱粒的全身过敏反应。那,生产和
IgE的传播在决定组织肥大细胞敏感性的强度和程度方面起着重要作用。
因此,至关重要的是,不仅了解B细胞IgE的产生和成熟是如何控制的,而且还要
IgE从原点到整个身体远端位点的原理。总体
该应用的目的是了解IgE生产和传播的生物学方面并获得
洞察这是如何影响过敏性疾病的。新兴文学和初步数据
申请人提出了一个普遍的假设,即生物学约束合作以限制IgE传播
稳态条件以及骨髓的积累长期浆细胞是一种异常
过敏性疾病的潜在系统表现。该假设将通过追求三个特定的特定来检验
目的是:1)确定IgE B细胞上IgE表达动力学的机制; 2)阐明
IgE分布从原点到效应位点的机制; 3)表征IgE等离子体
过敏患者的细胞。在第一个目标下,IgE mRNA剪接和IgE表面密度通常是
扰动以检查剪接偏置介导的稀释的IgE BCR密度独立的假设
GC B细胞演化潜力。在第二个目标下,解剖特定位置过敏挑战的模型
将部署以检查IgE分布在局部偏见的程度以及幼稚的作用
在此过程中,旁观者B细胞。在第三个目标下,健康和过敏性的骨髓质量
对于IGH同种型分解的深度测序以及单细胞转录组学将获得个体
阐明了长期严重过敏的患者IgE的细胞来源和生物学特性。
这项贡献很重要,因为有望阐明IgE如何更完整的情况
响应受到调节。最终,这种知识有可能告知新的发展
将有助于减少过敏性疾病日益严重的问题的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Duane R. Wesemann其他文献
IL-4 acts on skin-derived dendritic cells to promote the T<sub>H</sub>2 response to cutaneous sensitization and the development of allergic skin inflammation
- DOI:
10.1016/j.jaci.2024.06.021 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Juan Manuel Leyva-Castillo;Mrinmoy Das;Maria Strakosha;Alex McGurk;Emilie Artru;Christy Kam;Mohammed Alasharee;Duane R. Wesemann;Michio Tomura;Hajime Karasuyama;Frank Brombacher;Raif S. Geha - 通讯作者:
Raif S. Geha
Duane R. Wesemann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Duane R. Wesemann', 18)}}的其他基金
Cross-Protective Humoral Immunity to Coronavirus
对冠状病毒的交叉保护性体液免疫
- 批准号:
10842888 - 财政年份:2021
- 资助金额:
$ 68.65万 - 项目类别:
相似国自然基金
花生主要过敏原 Ara h 3 致敏的结构生物学基础
- 批准号:32372441
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鱼类过敏原小清蛋白广谱性模拟抗原的精准构筑及构效关系研究
- 批准号:32372439
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
过敏原特异性Th2记忆前体细胞鉴定及其形成机制研究
- 批准号:82371740
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色念珠菌过敏原通过CGRP-IL-21-PIEZO1轴促进T细胞-小胶质细胞-神经元通讯介导瘙痒
- 批准号:82371797
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
过敏原RNA疫苗促进过敏性鼻炎中嗜酸性粒细胞分泌保护素D1诱导Treg产生机制
- 批准号:82371122
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
开发高度敏感和特异的 POCT 测试哮喘触发过敏性 IgE
- 批准号:
10600767 - 财政年份:2023
- 资助金额:
$ 68.65万 - 项目类别:
Mast cell regulation of food allergen induced malaise through GDF15-GFRAL signaling
肥大细胞通过 GDF15-GFRAL 信号调节食物过敏原引起的不适
- 批准号:
10605915 - 财政年份:2023
- 资助金额:
$ 68.65万 - 项目类别:
Systemic and intercellular gene networks underlying RV-induced airways disease
RV 诱发气道疾病的全身和细胞间基因网络
- 批准号:
10741518 - 财政年份:2023
- 资助金额:
$ 68.65万 - 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10537469 - 财政年份:2022
- 资助金额:
$ 68.65万 - 项目类别: